Search results for "Chronic kidney disease"
Allopurinol not associated with increased mortality in patients with CKD, gout
The findings of a database analysis from the United Kingdom provide reassurance that a treat-to-target strategy has no apparent harmful effect on mortality in patients with gout and chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2022/01/25/2.htm
25 Jan 2022
ADA updates diabetes standards of care for 2023
The American Diabetes Association (ADA) has changed its recommendations on hypertension cutoffs, use of statins, and treatment of patients with diabetes and chronic kidney disease, among other topics.
https://immattersacp.org/weekly/archives/2022/12/20/1.htm
20 Dec 2022
Use of warfarin down, DOACs up in commercially insured patients with cirrhosis, nonvalvular afib
While more than half of eligible patients with cirrhosis and concurrent nonvalvular atrial fibrillation did not receive anticoagulation between 2012 and 2019, use of direct oral anticoagulants (DOACs) increased substantially during that time, a recent study found.
https://immattersacp.org/weekly/archives/2023/01/17/4.htm
17 Jan 2023
Inappropriate medications prescribed in some Medicare patients with CKD, study finds
Over a third of patients with chronic kidney disease (CKD) enrolled in a Medicare plan's Medication Therapy Management program in 2018 received a prescription for at least one potentially inappropriate medication.
https://immattersacp.org/weekly/archives/2021/02/02/5.htm
2 Feb 2021
Subjects sought for study of chronic kidney disease in adult type 2 diabetes patients
The National Kidney Foundation is looking for primary care physicians and their patients to participate in a multi-site cross-sectional study to estimate the prevalence of chronic kidney disease in adult type 2 diabetes patients.
https://immattersacp.org/weekly/archives/2011/06/14/10.htm
14 Jun 2011
MKSAP Quiz: Difficult-to-control hypertension
A 62-year-old man is evaluated during a follow-up visit for difficult-to-control hypertension. He also has chronic kidney disease and hyperlipidemia. Following a physical exam and lab studies, what is the most appropriate additional treatment?
https://immattersacp.org/weekly/archives/2021/08/24/3.htm
24 Aug 2021
Meta-analysis compares mortality benefits of heart failure treatment combinations
Patients taking an angiotensin receptor-neprilysin inhibitor, beta-blocker, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter-2 inhibitor showed the greatest reduction in risk of death, the analysis of heart failure with reduced ejection fraction found.
https://immattersacp.org/weekly/archives/2021/12/14/4.htm
14 Dec 2021
GLP-1 receptor agonists may offer kidney protection in patients with type 2 diabetes
An industry-conducted pooled analysis of two large trials of glucagon-like peptide-1 (GLP-1) receptor agonists found that both semaglutide and liraglutide slowed kidney function decline, with semaglutide appearing to have the greatest effect.
https://immattersacp.org/weekly/archives/2021/12/21/2.htm
21 Dec 2021
Cardiovascular events similar, adverse effects worse with chlorthalidone compared to hydrochlorothiazide
Chlorthalidone was associated with a significantly higher risk of hypokalemia, hyponatremia, acute renal failure, chronic kidney disease, type 2 diabetes, and abnormal weight gain.
https://immattersacp.org/weekly/archives/2020/02/25/2.htm
25 Feb 2020
Higher baclofen dosage associated with encephalopathy in older patients with CKD
A retrospective Canadian study compared 30-day risk for encephalopathy in older patients with chronic kidney disease (CKD) who were newly prescribed at least 20 mg of baclofen per day versus a lower dose, as well as in baclofen users versus nonusers.
https://immattersacp.org/weekly/archives/2019/11/12/4.htm
12 Nov 2019